Search

Author/Creator Chow, Christopher

2. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial. Issue 10313 (13th November 2021)

Authors:
Del Prato, Stefano; Kahn, Steven E; Pavo, Imre; Weerakkody, Govinda J; Yang, Zhengyu; Doupis, John; Aizenberg, Diego; Wynne, Alan G; Riesmeyer, Jeffrey S; Heine, Robert J; Wiese, Russell J; Ahmann, Andrew J; Arora, Samir; Ball, Eric M; Calderon, Rafael B; Butuk, David J; Chaychi, Leila; Chen, Mic...
Journal:
Lancet
Issue:
Volume 398:Issue 10313(2021)
Page Start:
1811
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens. (4th November 2015)

Authors:
Hanada, Ken-ichi; Chow, Christopher; Hoyos, Raul Gil; Gartner, Jared J; Prickett, Todd D; Somerville, Robert; Hogan, Katherine; Robbins, Paul F; Rosenberg, Steven A; Yang, James C
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens. Issue 2 (December 2015)

Authors:
Hanada, Ken-ichi; Chow, Christopher; Hoyos, Raul; Gartner, Jared; Prickett, Todd; Somerville, Robert; Hogan, Katherine; Robbins, Paul; Rosenberg, Steven; Yang, James
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗